Mukul Agrawal
Sudeep Pharma Limited · NSE
15,00,117 sh
SBI Healthcare Opportunities Fund
2.8% of their portfolio
₹164.52 Cr
13,60,000 sh
SBI Mutual Fund
Fund
₹160.00 Cr
40,00,000 sh
HDFC Manufacturing Fund
93.0% of their portfolio
₹100.41 Cr
8,30,000 sh
Goldman Sachs Funds - Goldman Sachs India Equity Portfolio
Investor
₹100.00 Cr
23,52,944 sh
SBI Comma Fund
6.7% of their portfolio
₹83.17 Cr
6,87,500 sh
SBI MNC Fund
1.2% of their portfolio
₹83.17 Cr
6,87,500 sh
SBI Retirement Benefit Fund - Aggressive Plan
1.6% of their portfolio
₹52.93 Cr
4,37,521 sh
Aditya Birla Sun Life Small Cap Fund
0.5% of their portfolio
₹25.97 Cr
3,06,092 sh
SBI Retirement Benefit Fund - Aggressive Hybrid Plan
1.4% of their portfolio
₹22.77 Cr
1,88,236 sh
ICICI Prudential MNC Fund
1.1% of their portfolio
₹18.90 Cr
2,54,717 sh
HDFC Innovation Fund
45.0% of their portfolio
₹14.46 Cr
1,19,504 sh
SBI Retirement Benefit Fund - Conservative Hybrid Plan
67.0% of their portfolio
₹1.71 Cr
14,128 sh
FIIs raised their stake +1.1pp QoQ
Sept 2026 quarter
Ownership by quarter
Promoter
— 0.0pp
Mukul Agrawal
Sudeep Pharma Limited · NSE
15,00,117 sh
Groww Mutual Fund (scheme IB18)
Sudeep Pharma Limited · NSE
465 sh · ₹5.61 L
HDFC Innovation Fund
Sudeep Pharma Limited · NSE
1,19,504 sh · ₹14.46 Cr
SBI Retirement Benefit Fund - Aggressive Plan
Sudeep Pharma Limited · NSE
4,37,521 sh · ₹52.93 Cr
SBI Healthcare Opportunities Fund
Sudeep Pharma Limited · NSE
13,60,000 sh · ₹164.52 Cr
SBI MNC Fund
Sudeep Pharma Limited · NSE
6,87,500 sh · ₹83.17 Cr
SBI Retirement Benefit Fund - Aggressive Hybrid Plan
Sudeep Pharma Limited · NSE
1,88,236 sh · ₹22.77 Cr
SBI Retirement Benefit Fund - Conservative Hybrid Plan
Sudeep Pharma Limited · NSE
14,128 sh · ₹1.71 Cr
SBI Comma Fund
Sudeep Pharma Limited · NSE
6,87,500 sh · ₹83.17 Cr
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
34 announcements on record for this company.
Promoter holding by quarter: Dec 2025 76.2%, Mar 2026 76.2%, Jun 2026 76.2%.
FII
— +0.3pp
FII holding by quarter: Dec 2025 1.7%, Mar 2026 1.6%, Jun 2026 1.8%.
DII
— −2.5pp
DII holding by quarter: Dec 2025 17.6%, Mar 2026 18.1%, Jun 2026 15.6%.
MF
— −0.7pp
MF holding by quarter: Dec 2025 5.7%, Mar 2026 6.2%, Jun 2026 5.5%.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
HDFC Manufacturing Fund
Sudeep Pharma Limited · NSE
8,30,000 sh · ₹100.41 Cr
Ownership by quarter
Promoter
— 0.0pp
Promoter holding by quarter: Dec 2025 76.2%, Mar 2026 76.2%, Jun 2026 76.2%.
FII
— +0.3pp
FII holding by quarter: Dec 2025 1.7%, Mar 2026 1.6%, Jun 2026 1.8%.
DII
— −2.5pp
DII holding by quarter: Dec 2025 17.6%, Mar 2026 18.1%, Jun 2026 15.6%.
MF
— −0.7pp
MF holding by quarter: Dec 2025 5.7%, Mar 2026 6.2%, Jun 2026 5.5%.
Per-series scale, bounds labeled. Gaps mark quarters without a filing.
The announcements library is part of Pro.
Every exchange filing this company makes — results, board meetings, dividends, analyst meets, investor presentations — as filed with NSE / BSE, the day it lands.
34 announcements on record for this company.